Home > > > > Report Detail

Global Adalimumab Biosimilar Market Insights: Impact of COVID-19 and Future Expectations to 2028

Publisher Name :
Date: 04-Jul-2023
No. of pages: 125

Adalimumab was a first fully humanized monoclonal antibody approved by US Food and Drug Administration (FDA) in 2002. Clinical efficacy and safety of adalimumab has been assessed in various trials in rheumatoid arthritis, ankylosing spondylitis, psoriasis, psoriatic arthritis, Crohn's Disease, and ulcerative colitis. It is one of the major sales success among biological and still one of the greatest blockbuster amongst monoclonal antibodies.

The Adalimumab Biosimilar market revenue was 2140.38 Million USD in 2022, and will reach 3063.35 Million USD in 2028, with a CAGR of 6.16% during 2022-2028.

This report elaborates the market size, market characteristics, and market growth of the Adalimumab Biosimilar industry, and breaks down according to the type, application, and consumption area of Adalimumab Biosimilar. The report also introduces players in the industry from the perspective of the industry chain and marketing chain and describes the leading companies.

In Chapter 2.3 of the report, the impact of the COVID-19 outbreak on the industry was fully assessed. Fully risk assessment and industry recommendations were made for Adalimumab Biosimilar in a special period. This chapter also compares the markets of Pre COVID-19 and Post COVID-19.

Chapter 2.5 covers the analysis of the impact of COVID-19 from the perspective of the industry chain.

In addition, chapters 6-10 consider the impact of COVID-19 on the regional economy.

Key players in the global Adalimumab Biosimilar market covered in Chapter 11:

Pfizer

Amgen

LG Life Sciences/Mochida Pharmaceutical

AET BioTech

Momenta Pharmaceuticals

Coherus Biosciences

Oncobiologics

Samsung Bioepsis

Zydus Cadila

Fujifilm Kyowa Kirin Biologics

Boehringer Ingelheim

Sandoz

In Chapter 3, on the basis of types, the Adalimumab Biosimilar market from 2018 to 2028 is primarily split into:

Exemptia

Adalirel

Cipleumab

Others

In Chapter 4, on the basis of applications, the Adalimumab Biosimilar market from 2018 to 2028 covers:

Hospital Pharmacy

Retail Pharmacy

Online Pharmacy

Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2018-2028) of the following regions are covered in Chapter 5, 6, 7, 8, 9, 10:

North America (Covered in Chapter 6)

United States

Canada

Mexico

Europe (Covered in Chapter 7)

Germany

UK

France

Italy

Spain

Russia

Others

Asia-Pacific (Covered in Chapter 8)

China

Japan

South Korea

Australia

India

Middle East and Africa (Covered in Chapter 9)

Saudi Arabia

UAE

Egypt

South Africa

South America (Covered in Chapter 10)

Brazil

Argentina

Columbia

Years considered for this report:

Historical Years: 2018-2022

Base Year: 2022

Estimated Year: 2023

Forecast Period: 2023-2028

Global Adalimumab Biosimilar Market Insights: Impact of COVID-19 and Future Expectations to 2028

Table of Content

1 Report Overview
1.1 Research Objectives
1.2 Study Scope
1.3 Key Market Segments
1.4 Market Investment Scenario Strategic

2 Industry Insights
2.1 Industry Ecosystem Analysis
2.1.1 Industry Chain Analysis
2.1.2 Distribution Channel Analysis
2.2 Market Trend Analysis
2.2.1 Growth Drivers
2.2.2 Industry Constraints and Challenges
2.3 Industry Trends Under COVID-19
2.3.1 Risk Assessment on COVID-19
2.3.2 Assessment of the Overall Impact of COVID-19 on the Industry
2.3.3 Pre COVID-19 and Post COVID-19 Market Scenario
2.4 Industry Innovation Prospect Analysis
2.5 The Impact of Covid-19 From the Perspective of Industry Chain

3 Global Adalimumab Biosimilar Market, By Product Type
3.1 Global Adalimumab Biosimilar Sales, Revenue and Market Share by Types (2018-2023)
3.1.1 Global Adalimumab Biosimilar Sales and Market Share by Types (2018-2023)
3.1.2 Global Adalimumab Biosimilar Revenue and Market Share by Types (2018-2023)
3.1.3 Global Adalimumab Biosimilar Price by Types (2018-2023)
3.2 Key Trends by Types
3.3 Global Adalimumab Biosimilar Sales, Price and Growth Rate of Exemptia (2018-2023)
3.4 Global Adalimumab Biosimilar Sales, Price and Growth Rate of Adalirel (2018-2023)
3.5 Global Adalimumab Biosimilar Sales, Price and Growth Rate of Cipleumab (2018-2023)
3.6 Global Adalimumab Biosimilar Sales, Price and Growth Rate of Others (2018-2023)

4 Global Adalimumab Biosimilar Market, By Applications
4.1 Global Adalimumab Biosimilar Consumption, Revenue and Market Share by Applications (2018-2023)
4.1.1 Global Adalimumab Biosimilar Consumption and Market Share by Applications (2018-2023)
4.1.2 Global Adalimumab Biosimilar Revenue and Market Share by Applications (2018-2023)
4.2 Hospital Pharmacy
4.3 Retail Pharmacy
4.4 Online Pharmacy

5 Global Adalimumab Biosimilar Market, By Regions
5.1 Global Adalimumab Biosimilar Market Sales and Market Share by Regions
5.1.1 Global Adalimumab Biosimilar Sales by Regions (2018-2023)
5.1.2 Global Adalimumab Biosimilar Sales Market Share by Regions (2018-2023)
5.2 Global Adalimumab Biosimilar Market Revenue and Market Share by Regions
5.2.1 Global Adalimumab Biosimilar Revenue by Regions (2018-2023)
5.2.2 Global Adalimumab Biosimilar Revenue Market Share by Regions (2018-2023)
5.3 Key Trends by Regions
5.3.1 Emerging Market Analysis

6 North America Adalimumab Biosimilar Market Analysis
6.1 North America Adalimumab Biosimilar Market Size
6.1.1 North America Adalimumab Biosimilar Market Sales and Growth Rate (2018-2023)
6.1.2 North America Adalimumab Biosimilar Market Revenue and Growth Rate (2018-2023)
6.2 U.S. Adalimumab Biosimilar Market Size
6.3 Canada Adalimumab Biosimilar Market Size
6.4 Mexico Adalimumab Biosimilar Market Size
6.5 Key Macroeconomic Indicators
6.6 The Influence of COVID-19 on North America Market

7 Europe Adalimumab Biosimilar Market Analysis
7.1 Europe Adalimumab Biosimilar Market Size
7.1.1 Europe Adalimumab Biosimilar Market Sales and Growth Rate (2018-2023)
7.1.2 Europe Adalimumab Biosimilar Market Revenue and Growth Rate (2018-2023)
7.2 Germany Adalimumab Biosimilar Market Size
7.3 United Kingdom Adalimumab Biosimilar Market Size
7.4 France Adalimumab Biosimilar Market Size
7.5 Italy Adalimumab Biosimilar Market Size
7.6 Spain Adalimumab Biosimilar Market Size
7.7 Russia Adalimumab Biosimilar Market Size
7.8 Key Macroeconomic Indicators
7.9 The Influence of COVID-19 on Europe Market

8 Asia-Pacific Adalimumab Biosimilar Market Analysis
8.1 Asia-Pacific Adalimumab Biosimilar Market Size
8.1.1 Asia-Pacific Adalimumab Biosimilar Market Sales and Growth Rate (2018-2023)
8.1.2 Asia-Pacific Adalimumab Biosimilar Market Revenue and Growth Rate (2018-2023)
8.2 China Adalimumab Biosimilar Market Size
8.3 Japan Adalimumab Biosimilar Market Size
8.4 South Korea Adalimumab Biosimilar Market Size
8.5 Australia Adalimumab Biosimilar Market Size
8.6 India Adalimumab Biosimilar Market Size
8.7 Key Macroeconomic Indicators
8.8 The Influence of COVID-19 on Asia Pacific Market

9 Middle East and Africa Adalimumab Biosimilar Market Analysis
9.1 Middle East and Africa Adalimumab Biosimilar Market Size
9.1.1 Middle East and Africa Adalimumab Biosimilar Market Sales and Growth Rate (2018-2023)
9.1.2 Middle East and Africa Adalimumab Biosimilar Market Revenue and Growth Rate (2018-2023)
9.2 Saudi Arabia Adalimumab Biosimilar Market Size
9.3 UAE Adalimumab Biosimilar Market Size
9.4 Egypt Adalimumab Biosimilar Market Size
9.5 South Africa Adalimumab Biosimilar Market Size
9.6 Key Macroeconomic Indicators
9.7 The Influence of COVID-19 on Middle East and Africa Market

10 South America Adalimumab Biosimilar Market Analysis
10.1 South America Adalimumab Biosimilar Market Size
10.1.1 South America Adalimumab Biosimilar Market Sales and Growth Rate (2018-2023)
10.1.2 South America Adalimumab Biosimilar Market Revenue and Growth Rate (2018-2023)
10.2 Brazil Adalimumab Biosimilar Market Size
10.3 Argentina Adalimumab Biosimilar Market Size
10.4 Columbia Adalimumab Biosimilar Market Size
10.5 Key Macroeconomic Indicators
10.6 The Influence of COVID-19 on South America Market

11 Competition Landscape and Company Profiles
11.1 Pfizer
11.1.1 Pfizer Basic Information
11.1.2 Pfizer Product Profiles, Application and Specification
11.1.3 Pfizer Adalimumab Biosimilar Market Performance (2018-2023)
11.2 Amgen
11.2.1 Amgen Basic Information
11.2.2 Amgen Product Profiles, Application and Specification
11.2.3 Amgen Adalimumab Biosimilar Market Performance (2018-2023)
11.3 LG Life Sciences/Mochida Pharmaceutical
11.3.1 LG Life Sciences/Mochida Pharmaceutical Basic Information
11.3.2 LG Life Sciences/Mochida Pharmaceutical Product Profiles, Application and Specification
11.3.3 LG Life Sciences/Mochida Pharmaceutical Adalimumab Biosimilar Market Performance (2018-2023)
11.4 AET BioTech
11.4.1 AET BioTech Basic Information
11.4.2 AET BioTech Product Profiles, Application and Specification
11.4.3 AET BioTech Adalimumab Biosimilar Market Performance (2018-2023)
11.5 Momenta Pharmaceuticals
11.5.1 Momenta Pharmaceuticals Basic Information
11.5.2 Momenta Pharmaceuticals Product Profiles, Application and Specification
11.5.3 Momenta Pharmaceuticals Adalimumab Biosimilar Market Performance (2018-2023)
11.6 Coherus Biosciences
11.6.1 Coherus Biosciences Basic Information
11.6.2 Coherus Biosciences Product Profiles, Application and Specification
11.6.3 Coherus Biosciences Adalimumab Biosimilar Market Performance (2018-2023)
11.7 Oncobiologics
11.7.1 Oncobiologics Basic Information
11.7.2 Oncobiologics Product Profiles, Application and Specification
11.7.3 Oncobiologics Adalimumab Biosimilar Market Performance (2018-2023)
11.8 Samsung Bioepsis
11.8.1 Samsung Bioepsis Basic Information
11.8.2 Samsung Bioepsis Product Profiles, Application and Specification
11.8.3 Samsung Bioepsis Adalimumab Biosimilar Market Performance (2018-2023)
11.9 Zydus Cadila
11.9.1 Zydus Cadila Basic Information
11.9.2 Zydus Cadila Product Profiles, Application and Specification
11.9.3 Zydus Cadila Adalimumab Biosimilar Market Performance (2018-2023)
11.10 Fujifilm Kyowa Kirin Biologics
11.10.1 Fujifilm Kyowa Kirin Biologics Basic Information
11.10.2 Fujifilm Kyowa Kirin Biologics Product Profiles, Application and Specification
11.10.3 Fujifilm Kyowa Kirin Biologics Adalimumab Biosimilar Market Performance (2018-2023)
11.11 Boehringer Ingelheim
11.11.1 Boehringer Ingelheim Basic Information
11.11.2 Boehringer Ingelheim Product Profiles, Application and Specification
11.11.3 Boehringer Ingelheim Adalimumab Biosimilar Market Performance (2018-2023)
11.12 Sandoz
11.12.1 Sandoz Basic Information
11.12.2 Sandoz Product Profiles, Application and Specification
11.12.3 Sandoz Adalimumab Biosimilar Market Performance (2018-2023)

12 Global Adalimumab Biosimilar Market Forecast, By Type and Applications
12.1 Global Adalimumab Biosimilar Market Forecast by Types (2023-2028)
12.1.1 Global Adalimumab Biosimilar Market Forecast Sales and Market Share by Types (2023-2028)
12.1.2 Global Adalimumab Biosimilar Market Forecast Revenue and Market Share by Types (2023-2028)
12.2 Global Adalimumab Biosimilar Market Forecast by Applications (2023-2028)
12.2.1 Global Adalimumab Biosimilar Market Forecast Consumption and Market Share by Applications (2023-2028)
12.2.2 Global Adalimumab Biosimilar Market Forecast Revenue and Market Share by Applications (2023-2028)

13 Global Adalimumab Biosimilar Market Forecast, By Regions
13.1 Global Adalimumab Biosimilar Market Forecast Sales and Market Share by Regions (2023-2028)
13.2 Global Adalimumab Biosimilar Market Forecast Revenue and Market Share by Regions (2023-2028)
13.3 North America Adalimumab Biosimilar Market Forecast (2023-2028)
13.4 Europe Adalimumab Biosimilar Market Forecast (2023-2028)
13.5 Asia-Pacific Adalimumab Biosimilar Market Forecast (2023-2028)
13.6 Middle East and Africa Adalimumab Biosimilar Market Forecast (2023-2028)
13.7 South America Adalimumab Biosimilar Market Forecast (2023-2028)

14 Appendix
14.1 Methodology
14.2 Research Data Source
14.2.1 Secondary Data
14.2.2 Primary Data
14.2.3 Market Size Estimation
14.2.4 Legal Disclaimer

List of Tables and Figures

Table Adalimumab Biosimilar Key Market Segments
Figure Global Adalimumab Biosimilar Market Size and Growth Rate 2018-2028
Figure Channel Status of Adalimumab Biosimilar
Table Market Driving Factors of Adalimumab Biosimilar
Table Market Industry Constraints and Challenges of Adalimumab Biosimilar
Figure Global COVID-19 Status
Figure Market Size Forecast Comparison of Pre COVID-19 and Post COVID-19
Table Global Adalimumab Biosimilar Sales by Types (2018-2023)
Table Global Adalimumab Biosimilar Sales Share by Types (2018-2023)
Table Global Adalimumab Biosimilar Revenue ($) by Types (2018-2023)
Table Global Adalimumab Biosimilar Revenue Share by Types (2018-2023)
Table Global Adalimumab Biosimilar Price by Types (2018-2023)
Figure Global Exemptia Sales and Growth Rate (2018-2023)
Figure Global Exemptia Price (2018-2023)
Figure Global Adalirel Sales and Growth Rate (2018-2023)
Figure Global Adalirel Price (2018-2023)
Figure Global Cipleumab Sales and Growth Rate (2018-2023)
Figure Global Cipleumab Price (2018-2023)
Figure Global Others Sales and Growth Rate (2018-2023)
Figure Global Others Price (2018-2023)
Table Global Adalimumab Biosimilar Consumption by Applications (2018-2023)
Table Global Adalimumab Biosimilar Consumption Share by Applications (2018-2023)
Table Global Adalimumab Biosimilar Revenue ($) by Applications (2018-2023)
Table Global Adalimumab Biosimilar Revenue Share by Applications (2018-2023)
Figure Global Hospital Pharmacy Consumption and Growth Rate (2018-2023) Sales and Growth Rate (2018-2023)
Figure Global Retail Pharmacy Consumption and Growth Rate (2018-2023) Sales and Growth Rate (2018-2023)
Figure Global Online Pharmacy Consumption and Growth Rate (2018-2023) Sales and Growth Rate (2018-2023)
Figure Global Adalimumab Biosimilar Sales and Growth Rate (2018-2023)
Table Global Adalimumab Biosimilar Sales by Regions (2018-2023)
Table Global Adalimumab Biosimilar Sales Market Share by Regions (2018-2023)
Figure Global Adalimumab Biosimilar Sales Market Share by Regions in 2022
Figure Global Adalimumab Biosimilar Revenue and Growth Rate (2018-2023)
Table Global Adalimumab Biosimilar Revenue by Regions (2018-2023)
Table Global Adalimumab Biosimilar Revenue Market Share by Regions (2018-2023)
Figure Global Adalimumab Biosimilar Revenue Market Share by Regions in 2022
Figure North America Adalimumab Biosimilar Market Sales and Growth Rate (2018-2023)
Table North America Adalimumab Biosimilar Sales by Countries (2018-2023)
Figure North America Adalimumab Biosimilar Market Revenue ($) and Growth Rate (2018-2023)
Table North America Adalimumab Biosimilar Revenue ($) by Countries (2018-2023)
Figure U.S. Adalimumab Biosimilar Market Sales and Growth Rate (2018-2023)
Figure U.S. Adalimumab Biosimilar Market Revenue and Growth Rate (2018-2023)
Figure Canada Adalimumab Biosimilar Market Sales and Growth Rate (2018-2023)
Figure Canada Adalimumab Biosimilar Market Revenue and Growth Rate (2018-2023)
Figure Mexico Adalimumab Biosimilar Market Sales and Growth Rate (2018-2023)
Figure Mexico Adalimumab Biosimilar Market Revenue and Growth Rate (2018-2023)
Figure North America COVID-19 Status
Figure Europe Adalimumab Biosimilar Market Sales and Growth Rate (2018-2023)
Table Europe Adalimumab Biosimilar Sales by Countries (2018-2023)
Figure Europe Adalimumab Biosimilar Market Revenue and Growth Rate (2018-2023)
Table Europe Adalimumab Biosimilar Revenue by Countries (2018-2023)
Figure Germany Adalimumab Biosimilar Market Sales and Growth Rate (2018-2023)
Figure Germany Adalimumab Biosimilar Market Revenue and Growth Rate (2018-2023)
Figure United Kingdom Adalimumab Biosimilar Market Sales and Growth Rate (2018-2023)
Figure United Kingdom Adalimumab Biosimilar Market Revenue and Growth Rate (2018-2023)
Figure France Adalimumab Biosimilar Market Sales and Growth Rate (2018-2023)
Figure France Adalimumab Biosimilar Market Revenue and Growth Rate (2018-2023)
Figure Italy Adalimumab Biosimilar Market Sales and Growth Rate (2018-2023)
Figure Italy Adalimumab Biosimilar Market Revenue and Growth Rate (2018-2023)
Figure Spain Adalimumab Biosimilar Market Sales and Growth Rate (2018-2023)
Figure Spain Adalimumab Biosimilar Market Revenue and Growth Rate (2018-2023)
Figure Russia Adalimumab Biosimilar Market Sales and Growth Rate (2018-2023)
Figure Russia Adalimumab Biosimilar Market Revenue and Growth Rate (2018-2023)
Figure Europe COVID-19 Status
Figure Asia-Pacific Adalimumab Biosimilar Market Sales and Growth Rate (2018-2023)
Table Asia-Pacific Adalimumab Biosimilar Sales by Countries (2018-2023)
Figure Asia-Pacific Adalimumab Biosimilar Market Revenue and Growth Rate (2018-2023)
Table Asia-Pacific Adalimumab Biosimilar Revenue by Countries (2018-2023)
Figure China Adalimumab Biosimilar Market Sales and Growth Rate (2018-2023)
Figure China Adalimumab Biosimilar Market Revenue and Growth Rate (2018-2023)
Figure Japan Adalimumab Biosimilar Market Sales and Growth Rate (2018-2023)
Figure Japan Adalimumab Biosimilar Market Revenue and Growth Rate (2018-2023)
Figure South Korea Adalimumab Biosimilar Market Sales and Growth Rate (2018-2023)
Figure South Korea Adalimumab Biosimilar Market Revenue and Growth Rate (2018-2023)
Figure Australia Adalimumab Biosimilar Market Sales and Growth Rate (2018-2023)
Figure Australia Adalimumab Biosimilar Market Revenue and Growth Rate (2018-2023)
Figure India Adalimumab Biosimilar Market Sales and Growth Rate (2018-2023)
Figure India Adalimumab Biosimilar Market Revenue and Growth Rate (2018-2023)
Figure Asia Pacific COVID-19 Status
Figure Middle East and Africa Adalimumab Biosimilar Market Sales and Growth Rate (2018-2023)
Table Middle East and Africa Adalimumab Biosimilar Sales by Countries (2018-2023)
Figure Middle East and Africa Adalimumab Biosimilar Market Revenue and Growth Rate (2018-2023)
Table Middle East and Africa Adalimumab Biosimilar Revenue by Countries (2018-2023)
Figure Saudi Arabia Adalimumab Biosimilar Market Sales and Growth Rate (2018-2023)
Figure Saudi Arabia Adalimumab Biosimilar Market Revenue and Growth Rate (2018-2023)
Figure UAE Adalimumab Biosimilar Market Sales and Growth Rate (2018-2023)
Figure UAE Adalimumab Biosimilar Market Revenue and Growth Rate (2018-2023)
Figure Egypt Adalimumab Biosimilar Market Sales and Growth Rate (2018-2023)
Figure Egypt Adalimumab Biosimilar Market Revenue and Growth Rate (2018-2023)
Figure South Africa Adalimumab Biosimilar Market Sales and Growth Rate (2018-2023)
Figure South Africa Adalimumab Biosimilar Market Revenue and Growth Rate (2018-2023)
Figure South America Adalimumab Biosimilar Market Sales and Growth Rate (2018-2023)
Table South America Adalimumab Biosimilar Sales by Countries (2018-2023)
Figure South America Adalimumab Biosimilar Market Revenue and Growth Rate (2018-2023)
Table South America Adalimumab Biosimilar Revenue by Countries (2018-2023)
Figure Brazil Adalimumab Biosimilar Market Sales and Growth Rate (2018-2023)
Figure Brazil Adalimumab Biosimilar Market Revenue and Growth Rate (2018-2023)
Figure Argentina Adalimumab Biosimilar Market Sales and Growth Rate (2018-2023)
Figure Argentina Adalimumab Biosimilar Market Revenue and Growth Rate (2018-2023)
Figure Columbia Adalimumab Biosimilar Market Sales and Growth Rate (2018-2023)
Figure Columbia Adalimumab Biosimilar Market Revenue and Growth Rate (2018-2023)
Table Pfizer Company Profile
Table Pfizer Production, Value, Price, Gross Margin 2018-2023
Figure Pfizer Production and Growth Rate
Figure Pfizer Value ($) Market Share 2018-2023
Table Amgen Company Profile
Table Amgen Production, Value, Price, Gross Margin 2018-2023
Figure Amgen Production and Growth Rate
Figure Amgen Value ($) Market Share 2018-2023
Table LG Life Sciences/Mochida Pharmaceutical Company Profile
Table LG Life Sciences/Mochida Pharmaceutical Production, Value, Price, Gross Margin 2018-2023
Figure LG Life Sciences/Mochida Pharmaceutical Production and Growth Rate
Figure LG Life Sciences/Mochida Pharmaceutical Value ($) Market Share 2018-2023
Table AET BioTech Company Profile
Table AET BioTech Production, Value, Price, Gross Margin 2018-2023
Figure AET BioTech Production and Growth Rate
Figure AET BioTech Value ($) Market Share 2018-2023
Table Momenta Pharmaceuticals Company Profile
Table Momenta Pharmaceuticals Production, Value, Price, Gross Margin 2018-2023
Figure Momenta Pharmaceuticals Production and Growth Rate
Figure Momenta Pharmaceuticals Value ($) Market Share 2018-2023
Table Coherus Biosciences Company Profile
Table Coherus Biosciences Production, Value, Price, Gross Margin 2018-2023
Figure Coherus Biosciences Production and Growth Rate
Figure Coherus Biosciences Value ($) Market Share 2018-2023
Table Oncobiologics Company Profile
Table Oncobiologics Production, Value, Price, Gross Margin 2018-2023
Figure Oncobiologics Production and Growth Rate
Figure Oncobiologics Value ($) Market Share 2018-2023
Table Samsung Bioepsis Company Profile
Table Samsung Bioepsis Production, Value, Price, Gross Margin 2018-2023
Figure Samsung Bioepsis Production and Growth Rate
Figure Samsung Bioepsis Value ($) Market Share 2018-2023
Table Zydus Cadila Company Profile
Table Zydus Cadila Production, Value, Price, Gross Margin 2018-2023
Figure Zydus Cadila Production and Growth Rate
Figure Zydus Cadila Value ($) Market Share 2018-2023
Table Fujifilm Kyowa Kirin Biologics Company Profile
Table Fujifilm Kyowa Kirin Biologics Production, Value, Price, Gross Margin 2018-2023
Figure Fujifilm Kyowa Kirin Biologics Production and Growth Rate
Figure Fujifilm Kyowa Kirin Biologics Value ($) Market Share 2018-2023
Table Boehringer Ingelheim Company Profile
Table Boehringer Ingelheim Production, Value, Price, Gross Margin 2018-2023
Figure Boehringer Ingelheim Production and Growth Rate
Figure Boehringer Ingelheim Value ($) Market Share 2018-2023
Table Sandoz Company Profile
Table Sandoz Production, Value, Price, Gross Margin 2018-2023
Figure Sandoz Production and Growth Rate
Figure Sandoz Value ($) Market Share 2018-2023
Table Global Adalimumab Biosimilar Market Forecast Sales by Types (2023-2028)
Table Global Adalimumab Biosimilar Market Forecast Sales Share by Types (2023-2028)
Table Global Adalimumab Biosimilar Market Forecast Revenue ($) by Types (2023-2028)
Table Global Adalimumab Biosimilar Market Forecast Revenue Share by Types (2023-2028)
Table Global Adalimumab Biosimilar Market Forecast Consumption by Applications (2023-2028)
Table Global Adalimumab Biosimilar Market Forecast Consumption Share by Applications (2023-2028)
Table Global Adalimumab Biosimilar Market Forecast Revenue ($) by Applications (2023-2028)
Table Global Adalimumab Biosimilar Market Forecast Revenue Share by Applications (2023-2028)
Table Global Adalimumab Biosimilar Market Forecast Sales by Regions (2023-2028)
Table Global Adalimumab Biosimilar Market Forecast Sales Share by Regions (2023-2028)
Table Global Adalimumab Biosimilar Market Forecast Revenue ($) by Regions (2023-2028)
Table Global Adalimumab Biosimilar Market Forecast Revenue Share by Regions (2023-2028)
Figure North America Market Sales and Growth Rate Forecast (2023-2028)
Figure North America Market Revenue ($) and Growth Rate Forecast (2023-2028)
Figure Europe Market Sales and Growth Rate Forecast (2023-2028)
Figure Europe Market Revenue ($) and Growth Rate Forecast (2023-2028)
Figure Asia-Pacific Market Sales and Growth Rate Forecast (2023-2028)
Figure Asia-Pacific Market Revenue ($) and Growth Rate Forecast (2023-2028)
Figure Middle East and Africa Market Sales and Growth Rate Forecast (2023-2028)
Figure Middle East and Africa Market Revenue ($) and Growth Rate Forecast (2023-2028)
Figure South America Market Sales and Growth Rate Forecast (2023-2028)
Figure South America Market Revenue ($) and Growth Rate Forecast (2023-2028)
  • Global Biologics and Biosimilars Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 147
    According to our LPI (LP Information) latest study, the global Biologics and Biosimilars market size was valued at US$ 458090 million in 2023. With growing demand in downstream market, the Biologics and Biosimilars is forecast to a readjusted size of US$ 837640 million by 2030 with a CAGR of 9.0% during review period. The research report highlights the growth potential of the global Biologics and Biosimilars market. Biologics and Biosimilars are expected to show stable growth in the futu......
  • Global Biosimilar Drug Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 94
    According to our LPI (LP Information) latest study, the global Biosimilar Drug market size was valued at US$ million in 2023. With growing demand in downstream market, the Biosimilar Drug is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. The research report highlights the growth potential of the global Biosimilar Drug market. Biosimilar Drug are expected to show stable growth in the future market. However, product differentiation, reducing cost......
  • Global Biologics and Biosimilars Market 2024 by Company, Regions, Type and Application, Forecast to 2030
    Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 147
    According to our (Global Info Research) latest study, the global Biologics and Biosimilars market size was valued at USD 481830 million in 2023 and is forecast to a readjusted size of USD 842330 million by 2030 with a CAGR of 8.3% during review period. Biologics are very specific, highly effective medicines made in living cells, and historically this was often an animal. Biologics include hormones, cytokines, growth factors, vaccines, gene and cellular therapies, fusion proteins, insulin......
  • Global Biosimilars Market Research Report 2023, Forecast to 2028
    Published: 27-Dec-2023        Price: US 2680 Onwards        Pages: 167
    A biosimilar is a biologic medical product (also known as biologic) highly similar to another already approved biological medicine (the 'reference medicine'). Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Technol......
  • Global Biosimilars Professional Survey Report 2023, Forecast to 2028
    Published: 27-Dec-2023        Price: US 3280 Onwards        Pages: 133
    A biosimilar is a biologic medical product (also known as biologic) highly similar to another already approved biological medicine (the 'reference medicine'). Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Technol......
  • Global Biosimilars Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 07-Dec-2023        Price: US 3380 Onwards        Pages: 106
    Market Overview of Global Biosimilars market: According to our latest research, the global Biosimilars market looks promising in the next 5 years. As of 2022, the global Biosimilars market was estimated at USD 8203.97 million, and it's anticipated to reach USD 40650.01 million in 2028, with a CAGR of 30.57% during the forecast years. A biosimilar product is a biologic product that is approved based on demonstrating that it is highly similar to an FDA?approved biologic product......
  • Global Biologics and Biosimilars Professional Survey Report 2023, Forecast to 2028
    Published: 24-Nov-2023        Price: US 3280 Onwards        Pages: 134
    Biologics include a wide variety of products such as gene and cell therapies, therapeutic proteins, monoclonal antibodies, and vaccines. Biosimilars are highly similar to the reference product in terms of safety, purity and potency, but may have minor differences in clinically inactive components. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) da......
  • Global Biologics and Biosimilars Market Research Report 2023, Forecast to 2028
    Published: 24-Nov-2023        Price: US 2680 Onwards        Pages: 160
    Biologics include a wide variety of products such as gene and cell therapies, therapeutic proteins, monoclonal antibodies, and vaccines. Biosimilars are highly similar to the reference product in terms of safety, purity and potency, but may have minor differences in clinically inactive components. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) da......
  • Global Biosimilar Monoclonal Antibodies Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 16-Nov-2023        Price: US 3380 Onwards        Pages: 103
    Market Overview of Global Biosimilar Monoclonal Antibodies market: According to our latest research, the global Biosimilar Monoclonal Antibodies market looks promising in the next 5 years. As of 2022, the global Biosimilar Monoclonal Antibodies market was estimated at USD 5156.19 million, and it's anticipated to reach USD 14274.14 million in 2028, with a CAGR of 18.5% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and......
    • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs